Dr. Brent Norton, MD, MBA, ICD.D, is a visionary business leader in the life sciences industry with operational and director experience across several successful enterprises that have achieved significant product sales and returns for investors. He uses his cross-functional knowledge to develop strategy, raise capital, and build important relationships in the academic and business community. Dr. Norton founded PreMD, completing IPOs and listings on both TSX and AMEX. Operationally, he has built R&D and commercial operations, led transactions with AstraZeneca, Eli Lilly, L’Oreal, Parke Davis/Pfizer, etc., and taken products through the FDA to global out-licensing with Johnson & Johnson. He is a founding Director of Novadaq Technologies (TSX:NDQ, NASDAQ:NVDQ), which was one of Canada’s most valuable medical companies and was recently sold to Stryker Corporation. Dr. Norton has been an active member of several BODs in Canada and the US. He is a venture partner at Lumira Capital, executive chair and CEO of Ortho RTI, a member of the Research Committee for CAMH, an Advisory BOD member for the Ivey International Centre for Health Innovation, a director of Alpine Ontario, and past-president and director of the Osler Bluff Ski Club. His contributions to six companies have allowed early investors the opportunity to crystallize investment gains of over $2.5B.